Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04957745 · ClinicalTrials.gov registry record · NA
Understanding Visual Confusion Using Stereoscopic Displays
A NA study, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT04957745: Completed NA study, sponsored by Massachusetts Eye and Ear Infirmary.
NCT04957745 is a NA study that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04957745, a NA study, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
In this research study we want to test how people understand a visual scene when the same image is presented to both the eyes, but portions of these images are altered in terms of contrast, depth or in some cases motion.
Primary Outcome
(Total time the peripheral target in the visual confusion condition was visible) / (total viewing time (=1 min))
Interventions
- BEHAVIORAL Binocular visual confusion (unilateral opaque)
- BEHAVIORAL Unilateral monocular visual confusion (unilateral see-through)
- BEHAVIORAL Bilateral monocular visual confusion (bilateral see-through)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2022-07-27 |
| Phase | NA |
What the finished NCT04957745 record still lists
NCT04957745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Binocular visual confusion (unilateral opaque) is the first listed.
NCT04957745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04957745 about?
NCT04957745 is a clinical study titled "Understanding Visual Confusion Using Stereoscopic Displays". In this research study we want to test how people understand a visual scene when the same image is presented to both the eyes, but portions of these images are altered in terms of contrast, depth or in some cases motion.
What is the current status of trial NCT04957745?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2021-11-09. Estimated completion is 2022-07-27.
What interventions are being tested in trial NCT04957745?
The interventions under investigation include: Binocular visual confusion (unilateral opaque) (BEHAVIORAL), Unilateral monocular visual confusion (unilateral see-through) (BEHAVIORAL), Bilateral monocular visual confusion (bilateral see-through) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04957745?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04957745's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI